What to know about self-swabbing for HPV after FDA approves new kits [Video]

For the first time, women in the United States have the ability to self-collect a sample to screen for human papillomavirus (HPV).

This week, the U.S. Food and Drug Administration approved two self-swab tests from pharmaceutical companies Becton, Dickinson and Company (BD) and Roche Holding AG for “clinical” use, meaning in a private room inside a doctor’s office, mobile clinic or another health care setting.

The tests are not yet available for people to use at home.

MORE: Woman claims she got HPV-related cancer after nail salon visit

HPV is the most common sexually transmitted infection in the U.S. and can lead to several potentially deadly cancers, including cervical cancer.

Advocates hope that by having a less intrusive option, more women, especially those living in underserved areas, can get screened for HPV.

Here’s what you need to know about the infection and the …